Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06593496 · ClinicalTrials.gov registry record · NA

Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region Project 1 - Epidemiology (ACHIEVE P1-EPI)

A NA study of Hypertension and High Blood Pressure, sponsored by Wayne State University.

Recruiting
Registry status
NA
Development phase
1,000
Enrollment target
1
Study location

NCT06593496: Recruiting NA study of Hypertension and High Blood Pressure, sponsored by Wayne State University.

NCT06593496 is a NA study of Hypertension and High Blood Pressure that is actively recruiting participants, run by Wayne State University. The registered enrollment target is 1,000 participants, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06593496, a NA study of Hypertension and High Blood Pressure, is actively recruiting participants, sponsored by Wayne State University.

RECRUITING
Registry status
NA
Development phase
1,000 participants
Enrollment target
1
Study location

Study Summary

This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In Populations Through Early PreVEntion in the GREAT LakEs Region) Center (IRB# 100221MP2A), the purpose of which is to improve cardiometabolic health in two uniquely comparable cities: Detroit, Michigan, and Cleveland, Ohio. The ACHIEVE GREATER Center involves separate but related projects that aim to improve cardiometabolic health outcomes through better risk factor control for three chronic conditions that are of tremendous public health importance, (hypertension (HTN), heart failure, and coronary heart disease), all of which contribute significantly to premature death in Detroit and Cleveland. The present study is the prospective observational cohort component of ACHIEVE P1- EPI (Project 1) of the ACHIEVE GREATER Center and serves to characterize the population of patients with blood pressure (BP) levels above normal attending The Wayne Health Mobile Health Unit (MHU) events to better understand key factors (e.g., social determinants of health) that convey information about baseline BP levels and related clinical outcomes (e.g., follow-up clinic visits, BP control, and cardiovascular events).

Primary Outcome

Achieve a minimum of six (6) measurements of two (2) or more readings of systolic and diastolic blood pressures at baseline, Month 6 and Month 11 within a seven (7) day period.

Interventions

  • BEHAVIORAL Text Message Reminder

Study Locations (1)

Michigan

  • Wayne Health Mobile Units - Detroit

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2025-06-11
Est. Completion 2028-06-01
Phase NA
Wayne State University

163 total trials

What NCT06593496 shows while recruiting

NCT06593496 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (71% lower).

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Text Message Reminder is the first listed.

NCT06593496 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT06593496 about?

NCT06593496 is a clinical study titled "Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region Project 1 - Epidemiology (ACHIEVE P1-EPI)". This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In Populations Through Early PreVEntion in the GREAT LakEs Region) Center (IRB# 100221MP2A), the purpose of which is to improve cardiometabolic health in two uniquely comparable cities: Detroit, Michigan, and Cleveland, O...

What is the current status of trial NCT06593496?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2025-06-11. Estimated completion is 2028-06-01.

What conditions does trial NCT06593496 study?

This clinical trial studies the following conditions: Hypertension, High Blood Pressure.

What interventions are being tested in trial NCT06593496?

The interventions under investigation include: Text Message Reminder (BEHAVIORAL).

Who is sponsoring clinical trial NCT06593496?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06593496 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06593496's enrollment target sits among peer trials

1,000 65th of 470 higher than 396 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06593496, the US trial registry maintained by the National Library of Medicine. NCT06593496 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.